[1]
S. Vidović, “Prevalence of five pharmacologically most important CYP2C9 and CYP2C19 allelic variants in the population from the Republic of Srpska in Bosnia and Herzegovina”, Arh Hig Rada Toksikol, vol. 72, no. 2, May 2021, doi: 10.2478/aiht-2021-72-3499.